Evidence map›Paper›PMID 21123167›Full record

ArticleThe Journal of biological chemistry2011

A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.

Fabio Rabelo Melo, Ida Waern, Elin Rönnberg, Magnus Åbrink, David M Lee, Susan M Schlenner, Thorsten B Feyerabend, Hans-Reimer Rodewald, Boris Turk, Sara Wernersson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Heparan Sulfate Proteoglycans in Immunity.Proteoglycan research · 2026
    Article
  5. Article
  6. Matrix proteoglycans in tumor inflammation and immunity.American journal of physiology. Cell physiology · 2022
    Review
  7. Article
  8. Novel Strategies to Target Mast Cells in Disease.Journal of innate immunity · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Mast cell function: a new vision of an old cell.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2014
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Fabio Rabelo MeloDepartment of Anatomy, Physiology, and Biochemistry, Swedish University of Agricultural Sciences, SE-75123 Uppsala, Sweden.
Ida Waern
Elin Rönnberg
Magnus Åbrink
David M Lee
Susan M Schlenner
Thorsten B Feyerabend
Hans-Reimer Rodewald
Boris Turk
Sara Wernersson
Gunnar Pejler
Swedish University of Agricultural Sciences · SEUniversität Ulm · DEBrigham and Women's Hospital · USJožef Stefan Institute · SIUppsala University · SE

Funding

Synovial Mast Cells in Inflammatory ArthritisR01AI059746 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 2004 to 2013
$3.3M
European Research Council 233074NIAID NIH HHS R01 AI 059746NIAID NIH HHS R01 AI059746
6 · The paper itself

Abstract

Mast cell secretory granules (secretory lysosomes) contain large amounts of fully active proteases bound to serglycin proteoglycan. Damage to the granule membrane will thus lead to the release of serglycin and serglycin-bound proteases into the cytosol, which potentially could lead to proteolytic activation of cytosolic pro-apoptotic compounds. We therefore hypothesized that mast cells are susceptible to apoptosis induced by permeabilization of the granule membrane and that this process is serglycin-dependent. Indeed, we show that wild-type mast cells are highly sensitive to apoptosis induced by granule permeabilization, whereas serglycin-deficient cells are largely resistant. The reduced sensitivity of serglycin(-/-) cells to apoptosis was accompanied by reduced granule damage, reduced release of proteases into the cytosol, and defective caspase-3 activation. Mechanistically, the apoptosis-promoting effect of serglycin involved serglycin-dependent proteases, as indicated by reduced sensitivity to apoptosis and reduced caspase-3 activation in cells lacking individual mast cell-specific proteases. Together, these findings implicate serglycin proteoglycan as a novel player in mast cell apoptosis.

Indexed as

AnimalsApoptosisCaspase 3Enzyme ActivationIntracellular MembranesMast CellsMiceMice, KnockoutPermeabilityProteoglycansSecretory VesiclesVesicular Transport ProteinsCasp3 protein, mouseCaspase 3ProteoglycansserglycinVesicular Transport Proteins

Identifiers

PMID21123167
PMCPMC3037655
OpenAlexW2055717919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.